The results suggested that plasma MTBR-tau243 could help estimate the tauopathy load in Alzheimer's disease, improving ...

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

“These findings reaffirm that the current Ocrevus IV 600 mg is optimally dosed to significantly slow disability progression,” ...

Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...

Survey finds that 59 per cent of those planning a family have concerns about the slow pace of newborn screening expansion ...

The first will be a study of a Novartis drug, injected monthly ... Maron and other preventive cardiologists, including Gulati ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

IoT helps to decentralise clinical trials, allowing them to become increasingly patient-centric and diverse while providing ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...

Novartis has launched a digital health innovation ... assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia. The importance of biosimilars only continues ...